Retatrutide (weight loss - investigational) Article: Retatrutide for Weight Loss (Investigational) Retatrutide is an experimental peptide that activates three metabolic receptorsGLP-1 (reduces appetite, slows digestion), GIP (improves insulin response) and glucagon (burns fat and calories)
Storage & Handling Store between 15 C and 30 C, protected from light
Recent breakthrough research in 2024 demonstrated that 5-amino-1MQ combined with exercise training in aged murine models produced enhanced adaptations compared to exercise alone, with grip strength improvements of approximately 60% and alterations in daily locomotor activity patterns with modified recovery kinetics
As absorption is reduced, body stores become low and a deficiency occurs Underlying diseases most commonly include: IBD (inflammatory bowel disease) Intestinal cancer (especially small cell lymphoma) Liver disease Pancreatitis and other pancreatic diseases Symptoms of low B12 levels Typically found in middle-aged or older cats that present with: Weight loss Diarrhea Vomiting Anorexia Thickened intestines In humans, B12 deficiency may also be associated with dementia, cardiovascular disease, and a certain type of anemia, although these are not specifically recognized problems in cats
Safety and efficacy for this formulation have not been evaluated by the FDA
